Oncimmune Share News (ONC)

Oncimmune Information

Buy ONC Shares
Add ONC to Watchlist
Add ONC to Alert

Share Price Information for Oncimmune (ONC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 25.40

Bid: 22.00

Ask: 24.00

Change: -1.10 (-4.56%)

Spread: 2.00 (9.091%)

Open: 25.40

High: 25.40

Low: 25.40

Prev. Close: 24.10

Last checked at -

UK Earnings, Trading Statements Calendar - Next 7 Days

Mon, 08th Feb 2021 16:09

Tuesday 9 February
Amino Technologies PLC	Full Year Results
Bellway PLC	Trading Statement
DFS Furniture PLC	Half Year Results
Discoverie Group PLC	Trading Statement
Mattioli Woods PLC	Half Year Results
Micro Focus International PLC	Full Year Results
Ocado Group PLC	Full Year Results
RM PLC	Full Year Results
St Modwen Properties PLC	Full Year Results
Tui AG	Q1 Results
Wednesday 10 February
Redrow PLC	Half Year Results
Smurfit Kappa Group PLC	Full Year Results
Avingtrans PLC	Half Year Results
RWS Holdings PLC	Trading Statement
Grainger PLC	Trading Statement
Ashmore Group PLC	Half Year Results
Dunelm Group PLC	Half Year Results
Lancashire Holdings Ltd	Full Year Results
Thursday 11 February
Ted Baker PLC	Trading Statement
Coca-Cola HBC AG	Full Year Results
S&U PLC	Trading Statement
RELX PLC	Full Year Results
MJ Gleeson PLC	Half Year Results
Coca-Cola European Partners PLC	Q4 Results
AstraZeneca PLC	Full Year Results
Friday 12 February
Victrex PLC	Trading Statement
Yamana Gold Inc	Full Year Results
Monday 15 February
City of London Investment Group PLC	Half Year Results
Grit Real Estate Income Group Ltd	Half Year Results
Oncimmune Holdings PLC	Half Year Results

Copyright 2021 Alliance News Limited. All Rights Reserved

More News

17 Feb 2022 22:13

TRADING UPDATES: Novacyt gets UK approval; Nostra spuds Cypress well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

17 Feb 2022 09:09

Oncimmune's EarlyCDT Lung test granted approval by Ministry of Health for Aragon

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that its EarlyCDT Lung test had been granted approval by the Ministry of Health for Aragon in Spain and will now be adopted in the University Hospital Miguel Servet in Zaragoza.

15 Feb 2022 22:16

TRADING UPDATES: Burford, Frenkel Topping expect contrasting results

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

31 Dec 2021 11:20

Oncimmune reports fresh research from Cedars-Sinai Covid study

(Sharecast News) - Oncimmune announced the publication of a paper arising from the research collaboration with Cedars-Sinai Medical Center in Los Angeles on Friday, focusing on the sex-specific autoimmune reactivity to SARS-CoV-2 - the virus which causes Covid-19 - following mildly symptomatic infection.

31 Dec 2021 08:32

Oncimmune study suggests antibodies spike following Covid infection

21 Dec 2021 14:25

Oncimmune shares up after multiple commercial contract wins

21 Dec 2021 13:07

Oncimmune signs new commercial contracts

(Sharecast News) - Oncimmune Holdings announced on Tuesday that it has signed further commercial contracts within its 'ImmunoINSIGHTS' pharma services business.

19 Nov 2021 16:06

UK shareholder meetings calendar - next 7 days

2 Nov 2021 15:55

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

2 Nov 2021 09:57

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

26 Oct 2021 16:03

UK earnings, trading statements calendar - next 7 days

20 Sep 2021 13:47

Oncimmune inks profiling contract with unnamed global pharma company

20 Sep 2021 11:24

Oncimmune inks deal with global pharma firm

(Sharecast News) - Immunodiagnostics company Oncimmune has signed an autoantibody profiling agreement with an unnamed global pharmaceutical company, it announced on Monday, to evaluate the autoantibody profiles of patient samples in various autoimmune diseases.

23 Aug 2021 15:12

Oncimmune upbeat on three-year lung cancer test study

(Sharecast News) - Immunodiagnostics group Oncimmune announced the pre-publication of the three-year follow-up data for the 'Early detection of Cancer of the Lung Scotland' (ECLS) trial on Monday, which showed that after three years, the number of late-stage cancers and deaths were lower in patients tested with the 'EarlyCDT Lung' blood test.

Latest Share Chat

Oncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Login to your account

Quickpicks are a member only feature

Login to your account